Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Geneyork Pharmaceuticals, officially known as Beijing Jingfeng Pharmaceutical Co., Ltd., is a leading Chinese pharmaceutical manufacturer and a core subsidiary of the China Meheco Group. The company specializes in the development and production of high-quality chemical drugs, with a particular emphasis on generic formulations for chronic diseases such as hypertension and diabetes. Geneyork operates state-of-the-art, GMP-certified facilities in Beijing, producing a wide range of oral solids and injectable medications. As a key player in the Chinese domestic market, the company focuses on providing affordable and effective therapeutic solutions, including its widely used metformin and amlodipine products. Through its integration with China Meheco, Geneyork leverages extensive distribution networks to ensure broad access to its essential medicines across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Geneyork Pharms.